… Our findings suggest a significant increase in prevalence of drug resistance over time since
antiretroviral rollout in regions of sub-Saharan Africa; this rise is driven by NNRTI resistance …

… to minimize HIV drug resistance are suboptimal. Factors that might mitigate these trends
include the adoption of regimens with lower barriers to resistance and technologies that could …

… HIVDR enable robust estimates which facilitate their interpretation, comparison, assessment
of national and global trends, and appropriate responses to increasing levels of resistance. …

… This study describes antiretroviral treatment and associated drug resistance mutations in
Swedish HIV-patients over time and shows how out-phasing of older drugs has been followed …

… A major finding of this work is the divergent temporal trends in drug resistance with B vs.
non-B subtypes and CRFs. Although not strictly, these categories tend to represent high- and low…

… on the transmission of drug-resistant HIV, with a major emphasis on the time trends of drug
… Continuous global surveillance is needed to monitor the circulating HIV strains and ensure …

… Two large data sets have been recently published, providing reliable estimates on the
prevalence of antiretroviral resistance in Europe and United States. In Europe, the results from the …

… antiretroviral therapy (ART) programme in the world. We assessed temporal trends in
pretreatment HIV-1 drug resistance (… -resistant HIV from a person with acquired drug resistance (…

… global scale-up of ARV therapy has reduced deaths from HIV/AIDS and the incidence of HIV
infection in LMICs, but the development of resistance to ARV … HIV resistant to ARV therapy. …

… The free antiretroviral therapy programme in India is globally the … of resistance and temporal
trends in individual resistance mutations. The development of resistance among the ARV-…